Trial Profile
Multicenter study of combination therapy using mizoribine, cyclosporin, basiliximab and steroids in kidney transplantation.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Jun 2016
Price :
$35
*
At a glance
- Drugs Mizoribine (Primary) ; Basiliximab; Ciclosporin; Corticosteroids; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 01 Feb 2012 Planned End Date (1 May 2013) added as reported by University Hospital Medical Information Network - Japan.
- 01 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 01 Jul 2009 Planned number of patients (70) identified as reported by University Hospital Medical Information Network - Japan record.